Population and Public Health
This week's top stories include strong support for the passage of the Social Determinants Accelerator Act of 2021 and the Supreme Court agreeing to decide the legality of drug payment cuts to 340B hospitals.
        
        
          Hospitals and health systems saw performance improvements in April compared to previous year; Google helps fund a data visualization tool that displays the scale and disparate impacts of COVID-19 cases.
 
        
        
          VisualDx's Dr. Art Papier and Dr. Nada Elbuluk discuss how Project Impact works to address health inequities and racial bias in AI.
        
        
          Dr. Deborah Maufi, chief medical officer at Babymoon Care, discusses how to tackle the inequalities in maternal health.
        
        
          This week's top stories include the Biden administration aiming to get 70% of adults at least one vaccine dose by July 4, ransomware continuing to be a threat to healthcare, and Collective Health scaling its employer health benefits platform.
        
        
          Monthly Update: HIMSS Media Editor in Chief Jonah Comstock recaps some of April's biggest stories, including insurtech news, studies from Fitbit and telehealth being called into question.
        
        
          Christine Czerniak, technical officer of the WHO Health Emergencies Programme, says variants of COVID-19 highlight the need for genomic surveillance and sequencing as well as the importance of collaboration in the fight against the coronavirus.
        
        
          
          HIMSS21 Europe
          
      
                    
            
  Professor Ran Balicer, chief innovation officer of Clalit Health Services, says Israel has found both innovation and data instrumental in tackling COVID-19 challenges and improving patient outcomes.
        
        
          There are four elements that make up the next stage in the evolution of population health, says Sita Kapoor, CIO at HealthEC.
        
        
          This week's top stories include the AstraZeneca vaccine showing 79% efficacy but facing questions about using outdated information, Everlywell forming a new at-home lab testing subsidiary, and the VA reviewing its EHR modernization program.
        
        
           
 
 
 
 
 
 
 
 
